Traws amends incentive plan to add 2M shares
Traws Pharma filed an amendment to its 2021 Incentive Compensation Plan, increasing authorized shares by 2 million. The changes require approval at the 2026 Annual Meeting and adjust vesting policies for employee status changes.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day